{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:05:09Z","timestamp":1763705109111,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jaad.2015.11.034","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T20:50:16Z","timestamp":1453495816000},"page":"709-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial"],"prefix":"10.1016","volume":"74","author":[{"given":"Andr\u00e9s M\u00e1r","family":"Erlendsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine Elisabeth","family":"Karmisholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Skovb\u00f8lling","family":"Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida-Marie","family":"Stender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete","family":"Haedersdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.11.034_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(97)70265-2","article-title":"Actinic keratoses","volume":"36","author":"Callen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.11.034_bib2","first-page":"CD004415","article-title":"Interventions for actinic keratoses (Review)","volume":"12","author":"Gupta","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jaad.2015.11.034_bib3","first-page":"1462","article-title":"The paradigm shift in treating actinic keratosis: a comprehensive strategy","volume":"11","author":"Stockfleth","year":"2012","journal-title":"J Drugs Dermatology"},{"key":"10.1016\/j.jaad.2015.11.034_bib4","unstructured":"Picato gel [product information]. Leo Pharma A\/S, Ballerup, Denmark; 2012."},{"key":"10.1016\/j.jaad.2015.11.034_bib5","unstructured":"European Medicines Agency. Ingenol mebutate. Available from: URL: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/002275\/human_med_001600.jsp&mid=WC0b01ac058001d124. Accessed July 11, 2015."},{"issue":"11","key":"10.1016\/j.jaad.2015.11.034_bib6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.11.034_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CCID.S28905","article-title":"New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel","volume":"5","author":"Berman","year":"2012","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaad.2015.11.034_bib8","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne","year":"2004","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.jaad.2015.11.034_bib9","first-page":"1181","article-title":"Ingenol mebutate-induced cell death patterns in normal and cancer epithelial cells","volume":"11","author":"Stahlhut","year":"2012","journal-title":"J Drugs Dermatology"},{"issue":"9","key":"10.1016\/j.jaad.2015.11.034_bib10","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"Kedei","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.034_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate","volume":"4","author":"Rosen","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.034_bib12","first-page":"1353","article-title":"Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT","volume":"13","author":"Berman","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"21","key":"10.1016\/j.jaad.2015.11.034_bib13","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.89.21.9991","article-title":"A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1","volume":"89","author":"Cronstein","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jaad.2015.11.034_bib14","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","article-title":"Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate","volume":"177","author":"Challacombe","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.034_bib15","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","article-title":"The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.034_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.034_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.11.034_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pa.19.040179.001143","article-title":"Mechanisms of glucocorticoid action on immune processes","volume":"19","author":"Parrillo","year":"1979","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.034_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0738-081X(97)00020-5","article-title":"Corticosteroids","volume":"15","author":"Hughes","year":"1997","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.034_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1535-7163.MCT-07-2060","article-title":"Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells","volume":"7","author":"Serova","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.034_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/jid.2011.418","article-title":"Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches","volume":"132","author":"Cozzi","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.034_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archderm.144.5.620","article-title":"Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial","volume":"144","author":"Faurschou","year":"2008","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.034_bib23","first-page":"1129","article-title":"Effect of topical corticosteroids on symptoms of clinical sunburn","volume":"7","author":"Russo","year":"1978","journal-title":"J Fam Pract"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.034_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/bjd.13284","article-title":"Topical corticosteroid reduces\u00a0inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial","volume":"171","author":"Wiegell","year":"2014","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.11.034_bib25","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jdv.13063","article-title":"Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial","volume":"29","author":"Samorano","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2 Suppl","key":"10.1016\/j.jaad.2015.11.034_bib26","first-page":"22","article-title":"Effective treatment of actinic keratosis with 0,5% fluorouracil cream for 1,2 or 4 weeks","volume":"70","author":"Weiss","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2015.11.034_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2133.2002.04561.x","article-title":"Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel","volume":"146","author":"Rivers","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.034_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1684\/ejd.2009.0692","article-title":"Treatment of multiple, multiform actinic keratoses on the head with imiquimod 5% cream","volume":"19","author":"Stockfleth","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.034_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2012.10893.x","article-title":"Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial","volume":"166","author":"Togsverd-Bo","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215025116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215025116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:12Z","timestamp":1759271892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215025116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0190962215025116"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}